Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer-Reference-Cited by-同舟云学术

Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer

Published:2016-01 Issue:1 Volume:27 Page:10-15
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Korn E.L.,Sachs M.C.,McShane L.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/1/10/16702030/mdv507.pdf

Reference18 articles.

1. Pathological complete response and accelerated drug approval in early breast cancer;Prowell;New Engl J Med,2012

2. Guidance for Industry: Pathological complete response in neoadjuvant treatment of high-risk early-stage breast cancer: use as an endpoint to support accelerated approval;US Food and Drug Administration,2014

3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

4. Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies;Berruti;J Clin Oncol,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating Large Language Models for Identifying Pathologic Complete Responses After Neoadjuvant Chemotherapy for Breast Cancer Using a Population-Based Pathologic Report Data;2024-03-19

2. Data Challenges for Externally Controlled Trials: Viewpoint;Journal of Medical Internet Research;2023-04-05

3. Regulatory implications of ctDNA in immuno-oncology for solid tumors;Journal for ImmunoTherapy of Cancer;2023-02

4. ASO Author Reflections: Development of Natural Language Processing-Based Machine-Learning Algorithms to Identify Pathologic Complete Response from Surgical Pathology Reports;Annals of Surgical Oncology;2022-12-22

5. A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System;Annals of Surgical Oncology;2022-12-21